Curaleaf Demands Engagement From Aurora Amid Fierce Acquisition Dispute
Curaleaf condemns Aurora Cannabis for rejecting its enhanced proposal, accusing the board of obstructing engagement and fair value.
Stocks · News reference
Curaleaf Cites Aurora Board's Fiduciary Duty Regarding Previously Recommended Shareholder Rejection Of Curaleaf's Enhanced Proposal
Curaleaf Holdings, Inc. (TSX:CURA) (OTCQX:CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer and medical cannabis products, today responded to Aurora Cannabis Inc.'s
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Aurora Cannabis' Board Recommends Shareholders Reject Offer By Curaleaf Holdings
Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX:ACB) (NASDAQ:ACB), the Canadian-based leading global medical cannabis company, today reconfirms that the Board of Directors (the "Board"), on
3 Huge Red Flags From Tilray's Q1 Earnings Report
Tilray Brands reported Q1 fiscal 2027 results with concerning fundamentals despite revenue growth. The company's cash burn spiked to $16.5 million (up from $1.3 million year-over-year), core cannabis revenue declined 13%, and operating expenses surged 83%. While top-line growth was driven by acquisitions like BrewDog, organic cannabis business weakness and ballooning costs suggest the stock faces continued headwinds.
8-K filing — Curaleaf Holdings, Inc. (CURLF)
Filed: 2026-10-19 AccNo: 0001756770-26-000130 Size: 1 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Aurora Cannabis Shareholders Urged For No Action Against Curaleaf's Hostile Acquisition Offer
Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NASDAQ: ACB), the Canadian-based leading global medical cannabis company, responded today to a press release issued by Curaleaf Holdings, Inc.
Curaleaf Proposes $4.00/Share Offer For Aurora Cannabis
Proposed Offer reflects a 45% premium to Aurora's 30-day VWAP and a 110% premium to Aurora's 30-day VWAP excluding balance sheet cash Provides Aurora shareholders with the opportunity to become owners of the